We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Pipettes Offer Quality Assurance for Endotoxin-Sensitive Applications

By LabMedica International staff writers
Posted on 11 May 2010
A range of serological pipettes is now certified nonpyrogenic to 0.01 ELISA Units (EU)/mL, significantly lower than the market standard of 0.25 EU/mL. More...
The range has also been validated nonhemolytic.

When medical device and pharmaceutical manufacturers perform tests to ensure that their products are free from endotoxins, it is extremely important for them to have confidence in the equipment and materials that they use.

Similarly, when pipetting blood and blood products, it is important that the polymer used does not have a detrimental effect on the sample. Validated nonhemolytic, the serological pipettes protect samples and provide valuable assurance that they will not interfere with the results of hemolysis tests.

Certified nonpyrogenic to a very low level, Sterilin (Bargoed, UK) serological pipettes greatly reduce the risk of endotoxin interference in routine laboratory analyses (such as limulus amebocyte lysate--LAL testing) and, therefore, help to ensure the integrity of results.

Sterilin serological pipettes are manufactured from crystal grade polystyrene to ensure excellent clarity. With crisp black print, ascending and descending graduations, and negative graduations for extra capacity, volumes are extremely easy to read, and accurate to ± 1%.

The comprehensive range includes standard pipette sizes (1 mL, 2 mL, 5 mL, 10 mL, 25 mL, and 50 mL) in addition to "Shortie” pipettes (5 mL and 10 mL), which are ideal for use in laminar flow cabinets. The gamma-irradiated pipettes are individually wrapped in paper peel or plastic film to maintain quality during storage.

Related Links:

Sterilin




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Automated Urinalysis Solution
UN-9000
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.